Gabrielle Paras, Roman Gulati, Steven M. Blinka, Ruben Raychaudhuri, Hiba M. Khan, Ashley Gagnon, Brianna Woo, Evan Y. Yu, Petros Grivas, Heather H. Cheng, Todd Yezefski, Rosa Nadal, Andrew Caleb Hsieh, Robert Bruce Montgomery, Peter Nelson, Michael Thomas Schweizer. "SPECTRA study: A phase II trial of supraphysiological androgen to enhance treatment activity with DNA-damaging agents in men with metastatic castration resistant prostate cancer (mCPRC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps279